Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease

References

• Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, et al. Immunotherapy for Alzheimer’s disease: from anti-β-amyloid to tau-based immunization strategies. Immunotherapy 2012; 4:213 - 38; http://dx.doi.org/10.2217/imt.11.170; PMID: 22339463
   PubMed Web of Science ®Google Scholar
• Schenk D. Amyloid-beta immunotherapy for Alzheimer’s disease: the end of the beginning. Nat Rev Neurosci 2002; 3:824 - 8; http://dx.doi.org/10.1038/nrn938; PMID: 12360327
   PubMed Web of Science ®Google Scholar
• Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 2003; 9:448 - 52; http://dx.doi.org/10.1038/nm840; PMID: 12640446
   PubMed Web of Science ®Google Scholar
• Hock C, Konietzko U, Streffer JR, Tracy J, Signorell A, Müller-Tillmanns B, et al. Antibodies against beta-amyloid slow cognitive decline in Alzheimer’s disease. Neuron 2003; 38:547 - 54; http://dx.doi.org/10.1016/S0896-6273(03)00294-0; PMID: 12765607
   PubMed Web of Science ®Google Scholar
• Panza F, Frisardi V, Imbimbo BP, Seripa D, Paris F, Santamato A, et al. Anti-β-amyloid immunotherapy for Alzheimer’s disease: focus on bapineuzumab. Curr Alzheimer Res 2011; 8:808 - 17; http://dx.doi.org/10.2174/156720511798192718; PMID: 21592055
   PubMed Web of Science ®Google Scholar
• Thomas K. Trials for Alzheimer’s drug halted after poor results. The New York Times 2012.
   Google Scholar
• Wang YJ, Pollard A, Zhong JH, Dong XY, Wu XB, Zhou HD, et al. Intramuscular delivery of a single chain antibody gene reduces brain Abeta burden in a mouse model of Alzheimer’s disease. Neurobiol Aging 2009; 30:364 - 76; http://dx.doi.org/10.1016/j.neurobiolaging.2007.06.013; PMID: 17686552
   PubMed Web of Science ®Google Scholar
• Wang YJ, Gao CY, Yang M, Liu XH, Sun Y, Pollard A, et al. Intramuscular delivery of a single chain antibody gene prevents brain Aβ deposition and cognitive impairment in a mouse model of Alzheimer’s disease. Brain Behav Immun 2010; 24:1281 - 93; http://dx.doi.org/10.1016/j.bbi.2010.05.010; PMID: 20595065
   PubMed Web of Science ®Google Scholar
• Cattepoel S, Hanenberg M, Kulic L, Nitsch RM. Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer’s disease. PLoS One 2011; 6:e18296; http://dx.doi.org/10.1371/journal.pone.0018296; PMID: 21483675
   PubMedGoogle Scholar
• Jacobson JS. Antibodies specific for epitopes within amyloid β (Aβ), for use in improving cognition. PCT Int Appl (2006), WO 2006066171 A1 20060622.
   Google Scholar
• Wisniewski T, Konietzko U. Amyloid-beta immunisation for Alzheimer’s disease. Lancet Neurol 2008; 7:805 - 11; http://dx.doi.org/10.1016/S1474-4422(08)70170-4; PMID: 18667360
   PubMed Web of Science ®Google Scholar
• Marín-Argany M, Rivera-Hernández G, Martí J, Villegas S. An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway. Biochem J 2011; 437:25 - 34; http://dx.doi.org/10.1042/BJ20101712; PMID: 21501114
   PubMed Web of Science ®Google Scholar
• Cheng IH, Scearce-Levie K, Legleiter J, Palop JJ, Gerstein H, Bien-Ly N, et al. Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem 2007; 282:23818 - 28; http://dx.doi.org/10.1074/jbc.M701078200; PMID: 17548355
   PubMed Web of Science ®Google Scholar
• Walsh DM, Selkoe DJ. A beta oligomers - a decade of discovery. J Neurochem 2007; 101:1172 - 84; http://dx.doi.org/10.1111/j.1471-4159.2006.04426.x; PMID: 17286590
   PubMed Web of Science ®Google Scholar
• Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003; 39:409 - 21; http://dx.doi.org/10.1016/S0896-6273(03)00434-3; PMID: 12895417
   PubMed Web of Science ®Google Scholar
• Clinton LK, Billings LM, Green KN, Caccamo A, Ngo J, Oddo S, et al. Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol Dis 2007; 28:76 - 82; http://dx.doi.org/10.1016/j.nbd.2007.06.013; PMID: 17659878
   PubMed Web of Science ®Google Scholar
• Mastrangelo MA, Bowers WJ. Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer’s disease-related pathologies in male triple-transgenic mice. BMC Neurosci 2008; 9:81; http://dx.doi.org/10.1186/1471-2202-9-81; PMID: 18700006
   PubMed Web of Science ®Google Scholar
• Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. Intraneuronal Abeta causes the onset of early Alzheimer’s disease-related cognitive deficits in transgenic mice. Neuron 2005; 45:675 - 88; http://dx.doi.org/10.1016/j.neuron.2005.01.040; PMID: 15748844
   PubMed Web of Science ®Google Scholar
• Giménez-Llort L, Blázquez G, Cañete T, Johansson B, Oddo S, Tobeña A, et al. Modeling behavioral and neuronal symptoms of Alzheimer’s disease in mice: a role for intraneuronal amyloid. Neurosci Biobehav Rev 2007; 31:125 - 47; http://dx.doi.org/10.1016/j.neubiorev.2006.07.007; PMID: 17055579
   PubMed Web of Science ®Google Scholar
• Giménez-Llort L, García Y, Buccieri K, Revilla S, Suñol C, Cristofol R, et al. Gender-specific neuroimmunoendocrine response to treadmill exercise in 3xTg-AD mice. Int J Alzheimers Dis 2010; 2010:128354; http://dx.doi.org/10.4061/2010/128354; PMID: 20981262
   PubMedGoogle Scholar
• García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, et al. Physical exercise protects against Alzheimer’s disease in 3xTg-AD mice. J Alzheimers Dis 2011; 24:421 - 54; PMID: 21297257
   PubMed Web of Science ®Google Scholar
• Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 2006; 440:352 - 7; http://dx.doi.org/10.1038/nature04533; PMID: 16541076
   PubMed Web of Science ®Google Scholar
• Movsesyan N, Ghochikyan A, Mkrtichyan M, Petrushina I, Davtyan H, Olkhanud PB, et al. Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine - a novel immunotherapeutic strategy. PLoS One 2008; 3:e2124; http://dx.doi.org/10.1371/journal.pone.0002124; PMID: 18461171
   PubMed Web of Science ®Google Scholar
• España J, Giménez-Llort L, Valero J, Miñano A, Rábano A, Rodriguez-Alvarez J, et al. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer’s disease transgenic mice. Biol Psychiatry 2010; 67:513 - 21; http://dx.doi.org/10.1016/j.biopsych.2009.06.015; PMID: 19664757
   PubMed Web of Science ®Google Scholar
• Calero M, Rostagno A, Matsubara E, Zlokovic B, Frangione B, Ghiso J. Apolipoprotein J (clusterin) and Alzheimer’s disease. Microsc Res Tech 2000; 50:305 - 15; http://dx.doi.org/10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; PMID: 10936885
   PubMed Web of Science ®Google Scholar
• Narayan P, Orte A, Clarke RW, Bolognesi B, Hook S, Ganzinger KA, et al. The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide. Nat Struct Mol Biol 2012; 19:79 - 83; http://dx.doi.org/10.1038/nsmb.2191; PMID: 22179788
   PubMed Web of Science ®Google Scholar
• Giménez-Llort L, Blázquez G, Cañete T, Rosa R, Vivó M, Oddo S, et al. Modeling neuropsychiatric symptoms of Alzheimer’s disease dementia in 3xTg-AD mice. In: Alzheimer’s Disease: New Advances. Iqbal K, Winblad B, Avila J, eds. Pianoro (BO), Italy: Medimond SRL,eds., 2006:513-516.
   Google Scholar
• Ratia M, Giménez-Llort L, Camps P, Muñoz-Torrero D, Clos MV, Badia A. Behavioural effects and regulation of PKCalpha and MAPK by huprine X in middle aged mice. Pharmacol Biochem Behav 2010; 95:485 - 93; http://dx.doi.org/10.1016/j.pbb.2010.03.013; PMID: 20363245
   PubMed Web of Science ®Google Scholar
• Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 11:47 - 60; http://dx.doi.org/10.1016/0165-0270(84)90007-4; PMID: 6471907
   PubMed Web of Science ®Google Scholar
• Klein WL. Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer’s disease?. J Alzheimers Dis 2013; 33:Suppl 1 S49 - 65; PMID: 22785404
   PubMed Web of Science ®Google Scholar
• McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease. Ann Neurol 1999; 46:860 - 6; http://dx.doi.org/10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; PMID: 10589538
   PubMed Web of Science ®Google Scholar
• Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, Camps P, et al. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice. Neurodegener Dis 2010; 7:379 - 88; http://dx.doi.org/10.1159/000287954; PMID: 20689242
   PubMed Web of Science ®Google Scholar
• Winton MJ, Lee EB, Sun E, Wong MM, Leight S, Zhang B, et al. Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration. J Neurosci 2011; 31:7691 - 9; http://dx.doi.org/10.1523/JNEUROSCI.6637-10.2011; PMID: 21613482
   PubMed Web of Science ®Google Scholar
• Gouras GK, Willén K, Tampellini D. Critical role of intraneuronal Aβ in Alzheimer’s disease: technical challenges in studying intracellular Aβ. Life Sci 2012; 91:1153 - 8; http://dx.doi.org/10.1016/j.lfs.2012.06.004; PMID: 22727791
   PubMed Web of Science ®Google Scholar
• LaFerla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer’s disease. Nat Rev Neurosci 2007; 8:499 - 509; http://dx.doi.org/10.1038/nrn2168; PMID: 17551515
   PubMed Web of Science ®Google Scholar
• Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 2004; 43:321 - 32; http://dx.doi.org/10.1016/j.neuron.2004.07.003; PMID: 15294141
   PubMed Web of Science ®Google Scholar
• Wegiel J, Kuchna I, Nowicki K, Frackowiak J, Mazur-Kolecka B, Imaki H, et al. Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration. Acta Neuropathol 2007; 113:389 - 402; http://dx.doi.org/10.1007/s00401-006-0191-4; PMID: 17237937
   PubMed Web of Science ®Google Scholar
• Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease. Neurobiol Aging 2003; 24:1063 - 70; http://dx.doi.org/10.1016/j.neurobiolaging.2003.08.012; PMID: 14643377
   PubMed Web of Science ®Google Scholar
• Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, Dobson CM, et al. The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J 2007; 21:2312 - 22; http://dx.doi.org/10.1096/fj.06-7986com; PMID: 17412999
   PubMed Web of Science ®Google Scholar
• Humphreys DT, Carver JA, Easterbrook-Smith SB, Wilson MR. Clusterin has chaperone-like activity similar to that of small heat shock proteins. J Biol Chem 1999; 274:6875 - 81; http://dx.doi.org/10.1074/jbc.274.11.6875; PMID: 10066740
   PubMed Web of Science ®Google Scholar
• Hammad SM, Ranganathan S, Loukinova E, Twal WO, Argraves WS. Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide. J Biol Chem 1997; 272:18644 - 9; http://dx.doi.org/10.1074/jbc.272.30.18644; PMID: 9228033
   PubMed Web of Science ®Google Scholar
• Nuutinen T, Suuronen T, Kauppinen A, Salminen A. Clusterin: a forgotten player in Alzheimer’s disease. Brain Res Rev 2009; 61:89 - 104; http://dx.doi.org/10.1016/j.brainresrev.2009.05.007; PMID: 19651157
   PubMed Web of Science ®Google Scholar
• Mahon MG, Lindstedt KA, Hermann M, Nimpf J, Schneider WJ. Multiple involvement of clusterin in chicken ovarian follicle development. Binding to two oocyte-specific members of the low density lipoprotein receptor gene family. J Biol Chem 1999; 274:4036 - 44; http://dx.doi.org/10.1074/jbc.274.7.4036; PMID: 9933595
   PubMed Web of Science ®Google Scholar
• DeMattos RB, Cirrito JR, Parsadanian M, May PC, O’Dell MA, Taylor JW, et al. ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 2004; 41:193 - 202; http://dx.doi.org/10.1016/S0896-6273(03)00850-X; PMID: 14741101
   PubMed Web of Science ®Google Scholar
• Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J, et al. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med 2004; 10:719 - 26; http://dx.doi.org/10.1038/nm1058; PMID: 15195085
   PubMed Web of Science ®Google Scholar
• Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, et al. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 2008; 118:4002 - 13; http://dx.doi.org/10.1172/JCI36663; PMID: 19033669
   PubMed Web of Science ®Google Scholar
• LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE. Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem 1994; 269:23403 - 6; PMID: 8089103
   PubMed Web of Science ®Google Scholar
• Youmans KL, Tai LM, Nwabuisi-Heath E, Jungbauer L, Kanekiyo T, Gan M, et al. APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease. J Biol Chem 2012; 287:41774 - 86; http://dx.doi.org/10.1074/jbc.M112.407957; PMID: 23060451
   PubMed Web of Science ®Google Scholar
• Kim J, Jiang H, Park S, Eltorai AE, Stewart FR, Yoon H, et al. Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-β amyloidosis. J Neurosci 2011; 31:18007 - 12; http://dx.doi.org/10.1523/JNEUROSCI.3773-11.2011; PMID: 22159114
   PubMed Web of Science ®Google Scholar
• Rivera-Hernández G, Marín-Argany M, Blasco-Moreno B, Bonet J, Oliva B, Villegas S. Elongation of the C-terminal domain of an anti-amyloid b single-chain variable fragment increases its thermodynamic stability and decreases its aggregation tendency. MAbs 2013; 5 In press
   Web of Science ®Google Scholar
• Lang UE, Lang F, Richter K, Vallon V, Lipp HP, Schnermann J, et al. Emotional instability but intact spatial cognition in adenosine receptor 1 knock out mice. Behav Brain Res 2003; 145:179 - 88; http://dx.doi.org/10.1016/S0166-4328(03)00108-6; PMID: 14529816
   PubMed Web of Science ®Google Scholar
• Wiltfang J, Arold N, Neuhoff V. A new multiphasic buffer system for sodium dodecyl sulfate-polyacrylamide gel electrophoresis of proteins and peptides with molecular masses 100,000-1000, and their detection with picomolar sensitivity. Electrophoresis 1991; 12:352 - 66; http://dx.doi.org/10.1002/elps.1150120507; PMID: 1718736
   PubMed Web of Science ®Google Scholar